Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01666002 · ClinicalTrials.gov registry record · NA

Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser

A NA study of Onychomycosis, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT01666002: Completed NA study of Onychomycosis, sponsored by Stanford University.

NCT01666002 is a NA study of Onychomycosis that has completed, run by Stanford University. The registered enrollment target is 27 participants, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01666002, a NA study of Onychomycosis, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The investigators would like to test the treatment of onychomycosis using a 0.65 millisecond pulsed 1064 nm laser fitted with a special onychomycosis handpiece. The investigators will compare the success rates of those receiving laser treatments with untreated patients. This study will provide a clinical basis for determining the relative effectiveness of an increasingly utilized treatment method.

Conditions Studied

Interventions

  • DEVICE Laser Treatment (Pulsed Nd:YAG 1064 nm Laser)

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2011-09
Est. Completion 2013-11
Phase NA
Stanford University

1,744 total trials

What the finished NCT01666002 record still lists

NCT01666002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 92-participant average among 11 other Onychomycosis trials with a reported enrollment target (71% lower).

The record links to 1 condition, with Onychomycosis appearing as the primary indexed condition, and to 1 intervention - of which Laser Treatment (Pulsed Nd:YAG 1064 nm Laser) is the first listed.

NCT01666002 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01666002 about?

NCT01666002 is a clinical study titled "Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser". The investigators would like to test the treatment of onychomycosis using a 0.65 millisecond pulsed 1064 nm laser fitted with a special onychomycosis handpiece. The investigators will compare the success rates of those receiving laser treatments with untreated patients. This study will provide a cli...

What is the current status of trial NCT01666002?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2011-09. Estimated completion is 2013-11.

What conditions does trial NCT01666002 study?

This clinical trial studies the following conditions: Onychomycosis.

What interventions are being tested in trial NCT01666002?

The interventions under investigation include: Laser Treatment (Pulsed Nd:YAG 1064 nm Laser) (DEVICE).

Who is sponsoring clinical trial NCT01666002?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01666002 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Onychomycosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01666002's enrollment target sits among peer trials

27 8th of 11 higher than 4 of 11 other Onychomycosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Onychomycosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00912041 · 27 participants · NA

    BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia

  • NCT02847559 · 27 participants · Phase 2

    Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

  • NCT03380195 · 27 participants · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT03384238 · 27 participants · Phase 1

    Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01666002, the US trial registry maintained by the National Library of Medicine. NCT01666002 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.